Načítá se...
Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk
Background: Systemic lupus erythematosus (SLE) is characterised by the presence of antibodies to double stranded DNA (dsDNA), which are involved in the pathogenesis of SLE. Previous studies showed that at least two thirds of patients develop a clinical relapse within six months after a significant r...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2003
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1754566/ https://ncbi.nlm.nih.gov/pubmed/12759290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.62.6.534 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|